Trials / Unknown
UnknownNCT04903665
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I
Gynecologic Malignancies Early-stage Detection by Liquid Biopsy in Peripheral Blood: a Prospective, Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 495 (actual)
- Sponsor
- Fudan University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective study aimed to develop and validate the performance of combined multi-omitcs assays for early detection of gynecologic cancers. Biomarkers of cfDNA methylation, ctDNA mutation and blood miRNA markers will be evaluated. The study will enroll approximately 495 female participants, including participants with gynecologic cancers or benign diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Multi-cancer early detection test | Blood collection and multi-cancer early detection testing |
Timeline
- Start date
- 2021-02-11
- Primary completion
- 2022-08-22
- Completion
- 2022-12-31
- First posted
- 2021-05-26
- Last updated
- 2022-07-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04903665. Inclusion in this directory is not an endorsement.